Saira Ramasastry - 11 Jul 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Director
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 11 Jul 2022
Net transactions value: -$86,200
Form type: 4
Filing time: 13 Jul 2022, 16:05:52 UTC
Previous filing: 27 Jun 2022
Next filing: 02 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Award	$63,800	+5,000	+62%	$12.76	13,092	11 Jul 2022	Direct
transaction	VIR	Common Stock	Sale	$150,000	-5,000	-38%	$30.00	8,092	11 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-5,000	-10%	$0.000000	42,777	11 Jul 2022	Common Stock	5,000	$12.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022.
F2	1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter.